Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Gastric Cancer|Liver Cancer|Melanoma (Skin)|Metastatic Cancer|Ovarian Cancer|Pancreatic Cancer
Interventions: DRUG: cyclophosphamide|DRUG: poly ICLC|PROCEDURE: hepatic artery embolization|RADIATION: 3-dimensional conformal radiation therapy
Sponsor: Rutgers, The State University of New Jersey